Microsurgical reconstruction of the through-and-through defect in head and neck cancer: Is it worth it?

被引:15
作者
Thoma, A
Veltri, K
Archibald, S
Jackson, S
Young, JEM
机构
[1] Div. of Plast. and Reconstr. Surgery, St. Joseph's Hospital, McMaster University, Hamilton, Ont.
[2] Div. of Plast. and Reconstr. Surgery, 200 James Street South, Hamilton
关键词
D O I
10.1055/s-2007-1000118
中图分类号
R61 [外科手术学];
学科分类号
摘要
As health resources diminish, there are compelling reasons to utilize health dollars in a fiscally responsible manner. The reconstruction of complex oromandibular defects involving mucosa, bone, and skin coverage poses one of the greatest challenges in microsurgery of the head and neck. The cancer patient who requires a through-and-through resection and microsurgical reconstruction usually has a poor prognosis. In this study, the authors examine whether this type of surgery is worthwhile in terms of cost, functional outcome, and patient satisfaction. Of 16 cases of through-and-through oromandibular reconstruction performed, the survival outcome of ten (n = 10) advanced cases requiring immediate oromandibular reconstruction (7 radial forearm flaps; 3 scapular flaps) is presented. Six cases were considered cured and required delayed reconstruction. Seven of the 10 patients died within 39 months postoperatively, while three survived up to 68 months postoperatively. The combined experience of these ten patients was examined using the Kaplan-Meier (product-limit) estimator of the survival curve. Results show that of the seven patients who died of disease, five did so within the first postoperative year. More important, among those Five patients who survived for more than one postoperative year, three were still alive up to 68 months, representing a combined total of over 15 postoperative years. The probability of long-term survival is good in through-and-through oromandibular cancer patients who can survive to 1 year postoperatively, and it is proposed that microsurgical reconstruction,albeit costly, remains a worthwhile procedure.
引用
收藏
页码:401 / 408
页数:8
相关论文
共 18 条
[1]   PSYCHOMETRIC VALIDATION OF THE EORTC CORE QUALITY-OF-LIFE QUESTIONNAIRE, 30-ITEM VERSION AND A DIAGNOSIS-SPECIFIC MODULE FOR HEAD AND NECK-CANCER PATIENTS [J].
BJORDAL, K ;
KAASA, S .
ACTA ONCOLOGICA, 1992, 31 (03) :311-321
[2]   THE THROUGH-AND-THROUGH OROMANDIBULAR DEFECT - RATIONALE FOR AGGRESSIVE RECONSTRUCTION [J].
BOYD, JB ;
MORRIS, S ;
ROSEN, IB ;
GULLANE, P ;
ROTSTEIN, L ;
FREEMAN, JL .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1994, 93 (01) :44-53
[3]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[4]   SQUAMOUS-CELL CARCINOMA ANTIGEN AS AN ADJUNCT TUMOR-MARKER IN PRIMARY-CARCINOMA OF THE LUNG [J].
CHEAH, PL ;
LIAM, CK ;
YAP, SF ;
LOOI, LM .
JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (06) :535-537
[5]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[6]  
List MA, 1996, HEAD NECK-J SCI SPEC, V18, P1
[7]   QUALITY-ADJUSTED LIFE YEARS, UTILITY-THEORY, AND HEALTHY-YEARS EQUIVALENTS [J].
MEHREZ, A ;
GAFNI, A .
MEDICAL DECISION MAKING, 1989, 9 (02) :142-149
[8]   Quantitative detection of soluble adhesion molecules in sera of melanoma patients correlates with clinical stage [J].
Schadendorf, D ;
Diehl, S ;
Zuberbier, T ;
Schadendorf, C ;
Henz, BM .
DERMATOLOGY, 1996, 192 (02) :89-93
[9]   SERUM MANGANESE SUPEROXIDE-DISMUTASE IS A NEW TUMOR-MARKER FOR MALIGNANT-MELANOMA [J].
SCHADENDORF, D ;
ZUBERBIER, T ;
DIEHL, S ;
SCHADENDORF, C ;
CZARNETZKI, BM .
MELANOMA RESEARCH, 1995, 5 (05) :351-353
[10]   IMMUNOHISTOCHEMICAL AND SEROLOGICAL EVALUATION OF CD44 SPLICE VARIANTS IN HUMAN OVARIAN-CANCER [J].
SLIUTZ, G ;
TEMPFER, C ;
WINKLER, S ;
KOHLBERGER, P ;
REINTHALLER, A ;
KAINZ, C .
BRITISH JOURNAL OF CANCER, 1995, 72 (06) :1494-1497